{"transactions":[{"id":1858693,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:55:10.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":4.84,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-23-070403","document":"tm2318426-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923070403/tm2318426-7_4seq1.xml","form_type":"4"}},{"id":2053711,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T11:28:02.000Z","date":"2023-01-15","kind":"grant","acquired":true,"shares":13875,"price":4,"value":55500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $55,500 in the aggregate owed to the Reporting Person for service on the board of directors in 2022."}],"balance_after":40747,"source":{"system":"sec-edgar","filing":"0001104659-23-004005","document":"tm233517-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923004005/tm233517-2_4seq1.xml","form_type":"4"}},{"id":2225334,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:02:21.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":2.62,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-22-073095","document":"tm2218674-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465922073095/tm2218674-3_4seq1.xml","form_type":"4"}},{"id":2688874,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T00:04:34.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest 25% every quarter after the grant date."}],"balance_after":3750,"derivative":{"exercise_price":20.92,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-21-075263","document":"tm2118079-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921075263/tm2118079-4_4seq1.xml","form_type":"4"}},{"id":2695080,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T01:32:21.000Z","date":"2021-05-26","kind":"purchase","acquired":true,"shares":1335,"price":19.03,"value":25405.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.66 to $19.43, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":26872,"source":{"system":"sec-edgar","filing":"0001104659-21-072621","document":"tm2117684-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921072621/tm2117684-5_4seq1.xml","form_type":"4"}},{"id":2695079,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T01:32:21.000Z","date":"2021-05-25","kind":"purchase","acquired":true,"shares":2715,"price":18.44,"value":50064.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.38 to $18.52, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":25537,"source":{"system":"sec-edgar","filing":"0001104659-21-072621","document":"tm2117684-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921072621/tm2117684-5_4seq1.xml","form_type":"4"}},{"id":2695078,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T01:32:21.000Z","date":"2021-05-24","kind":"purchase","acquired":true,"shares":600,"price":17.8,"value":10680.0,"ownership":{"direct":true},"balance_after":22822,"source":{"system":"sec-edgar","filing":"0001104659-21-072621","document":"tm2117684-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921072621/tm2117684-5_4seq1.xml","form_type":"4"}},{"id":2991036,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T01:14:48.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."}],"balance_after":7500,"derivative":{"exercise_price":11.38,"expiration_date":"2030-11-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-20-122032","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465920122032/a4.xml","form_type":"4"}},{"id":3009999,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-10-08T22:12:34.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":11111,"derivative":{"exercise_price":9,"expiration_date":"2023-06-02","underlying":"Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001209191-20-054316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054316/doc4.xml","form_type":"4"}},{"id":3009998,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-10-08T22:12:34.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":9,"expiration_date":"2023-06-02","underlying":"Series A Convertible Preferred Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001209191-20-054316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054316/doc4.xml","form_type":"4"}},{"id":3009997,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-08T22:12:34.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":22222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001209191-20-054316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054316/doc4.xml","form_type":"4"}},{"id":3009996,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":112437,"kind":"person","name":"Lefenfeld Michael","position":1,"cik":"0001826906","reported_name":"Lefenfeld Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T22:12:34.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":22222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001209191-20-054316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054316/doc4.xml","form_type":"4"}}]}